Table 2.
Multivariable analysis excluding ECM
| PFS | EGFR/ALK+ NSCLC | P | Wild Type | P |
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Age (<50 vs 50–60 vs >60) | 0.83 (0.60, 1.14) | 0.24 | 0.91 (0.73, 1.14) | 0.42 |
| KPS (<70 vs 70–80 vs >80) | 0.65 (0.43, 1.00) | 0.05 | 0.73 (0.59, 0.92) | 0.006 |
| Brain mets (1 vs 2–3 vs >3) | 0.92 (0.69, 1.22) | 0.56 | 1.22 (1.02, 1.46) | 0.029 |
| Symptomatic | 1.11 (0.64, 1.92) | 0.71 | 1.05 (0.74, 1.49) | 0.80 |
| Synchronous | 0.75 (0.45, 1.24) | 0.26 | 0.79 (0.58, 1.07) | 0.12 |
| OS | ||||
| Age (<50 vs 50–60 vs >60) | 1.28 (0.88, 1.86) | 0.20 | 1.05 (0.84, 1.33) | 0.65 |
| KPS (<70 vs 70–80 vs >80) | 0.35 (0.22, 0.55) | <0.001 | 0.70 (0.56, 0.89) | 0.004 |
| Brain mets (1 vs 2–3 vs >3) | 0.95 (0.69, 1.31) | 0.74 | 1.31 (1.08, 1.59) | 0.006 |
| Symptomatic | 0.87 (0.48, 1.60) | 0.66 | 0.97 (0.67, 1.40) | 0.85 |
| Synchronous | 0.69 (0.40, 1.19) | 0.18 | 0.83 (0.60, 1.15) | 0.25 |